Preliminary Program

Monday, October 13th

Time Event
16:00-18:00 Opening Ceremony
Mr. Mosibudi Mangena - South Africa's Commitment to AIDS Vaccine Development
Dr. Alan Bernstein - Developing an HIV Vaccine: Where do we go from here?
Dr. Malegapuru Makgoba - What Challenges/Opportunities Face African Scientists in the Development of an HIV Vaccine?
Dr. Stanley Plotkin - Sang-froid in a Time of Trouble
18:00 Opening Function

Tuesday, October 14th

Time Event
08:30–10:00 Plenary 1
Dr. Julie McElrath – Lessons Learned from Previous HIV Vaccine Trials
Mr. Pedro Goicochea – Community Involvement in HIV Prevention Research in the South
Dr. Dennis Burton – Neutralizing Antibodies and Protection Against HIV
10:00–10:30 Tea/Coffee Break
10:30 -12:30 Oral Abstract Session 1
Oral Abstract Session 2
Oral Abstract Session 3
12:30–13:30 Lunch
13:30–14:30 Poster Discussion Groups
14:30–15:30 Special Session 1
Innovations in AIDS Vaccine Discovery
Chair: Wayne Koff
Special Session 2
15:30–16:00 Tea/Coffee Break
16:00–18:00 Symposia 1
The Search for New and More Broadly Neutralizing Antibodies

Moderator: John Mascola

Round Table 1
Preparing for Future Efficacy Trials: Lessons from STEP/Phambili

Moderator: Barney Graham
Moderator: Glenda Gray

Debate 1
Should Animal Models be a Gatekeeper for Human Clinical Trials?

Moderator: Peggy Johnston
18:00 Gala Dinner

Wednesday, October 15th

Time Event
08:30–10:00 Plenary 2
Dr. Bruce Walker – Correlates of Protective Vaccine Induced T cell Immunity
Dr. Reidar Lie – Ethics and HIV Vaccine Trials in Developing Countries: Shifting the Focus to Research Policy
Dr. Judy Lieberman – Harnessing RNA Interference to Understand HIV and Prevent Transmission
10:00–10:30 Tea/Coffee Break
10:30-12:30 Oral Abstract Session 4
Oral Abstract Session 5
Oral Abstract Session 6
12:30–13:30 Lunch
13:30–15:30 Symposia 2
Biology of Vectors / Next Generation Vaccine Vectors

Moderator: Dan Barouch

Oral Abstract Session 7
Oral Abstract Session 8
15:30–16:00 Tea/Coffee Break
16:00–18:00 Symposia 3
Systems Biology to Unravel and Decipher the Interface Between Innate and Adaptive Immunity

Moderator: Rafick Sekaly

Round Table 2
Converging of Prevention Technologies

Moderator: Mitchell Warren

Debate 2
Should There be Further Large-scale Testing of T-cell Based Vaccines that do not Induce Broadly Neutralizing Antibodies?

Moderator: John Moore
18:00 Poster Viewing

Thursday, October 16th, 2008

Time Event
08:00–10:00 Plenary 3
Dr. Susan Buchbinder - HIV Vaccine Efficacy Trials: Past, Present and Future
Dr. Ronald Swanstrom - A New Look at the Transmitted Virus and its Source in the Genital Tract
Dr. James McIntyre - HIV Prevention: in Search of a Future
Dr. Guido Silvestri - Mucosal Immunity in HIV and SIV Infection
10:00–10:30 Tea/Coffee Break
10:30–11:30 Rapporteur Session
Dr. Edward Rybicki – Vaccine Concepts and Design
Dr. Galit Alter – T cell Immunology / Innate Immunity
Dr. Ralph Pantophlet – B cell Immunology / Neutralizing Antibody/ Mucosal Immunology
Dr. Jintanat Ananworanich – Clinical Trials
11:30–12:30 Late Breaker Abstracts
12:30–13:00 Closing and Handover
© 2005 Global HIV Vaccine Enterprise